These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7236375)

  • 61. [Changes in the percentual quota of lymphocytes in silicotics after intravenous treatment with ascorbic acid and lysozyme].
    Castriciano N
    Folia Med (Napoli); 1968 Nov; 51(11):864-81. PubMed ID: 5737863
    [No Abstract]   [Full Text] [Related]  

  • 62. [Symptomatic treatment of allergies and seasonal infections of the field of otorhinolaryngology].
    Bourguet J; Du Plessis De Grenedan Y; Dumeyniou P
    Ann Otolaryngol Chir Cervicofac; 1974; 91(10-11):633-8. PubMed ID: 4469758
    [No Abstract]   [Full Text] [Related]  

  • 63. [Clinical study of Madecassol in otorhinolaryngology].
    Riu R; Alavoine J; Auriault A; Le Mouel C
    J Med Lyon; 1966 Apr; 47(97):693-706. PubMed ID: 5940268
    [No Abstract]   [Full Text] [Related]  

  • 64. [Value of the association of formaldehyde and tyrothricin in a solution for local action in otorhinolaryngology].
    Grimaud ; Jeannin C
    J Fr Otorhinolaryngol Chir Maxillofac; 1965; 14(5):549-52. PubMed ID: 5853553
    [No Abstract]   [Full Text] [Related]  

  • 65. Combined effect of selenium and ascorbic acid on alcohol induced hyperlipidemia in male guinea pigs.
    Asha GS; Indira M
    Comp Biochem Physiol C Toxicol Pharmacol; 2004 Feb; 137(2):109-14. PubMed ID: 15050922
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Vitamin C as prophylactic drug against experimental hepatotoxicity.
    Soliman MA; Elwi AM; el-Kateb H; Kamel SH
    J Egypt Med Assoc; 1965; 48(11):806-12. PubMed ID: 5886659
    [No Abstract]   [Full Text] [Related]  

  • 67. Comparative study of the antitumor action between sodium 5,6-benzylidene-L-ascorbate and sodium ascorbate (minireview).
    Sakagami H; Satoh K; Kochi M
    Anticancer Res; 1997; 17(6D):4451-2. PubMed ID: 9494548
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Raubasine in otorhinolaryngology].
    Simon H; Siegl H
    Munch Med Wochenschr; 1972 Mar; 114(9):402-3. PubMed ID: 5067465
    [No Abstract]   [Full Text] [Related]  

  • 69. [Kymalzone in current O.R.L. practice in children].
    Danon J
    Ann Otolaryngol Chir Cervicofac; 1980 Dec; 97(12):1065-72. PubMed ID: 7018344
    [No Abstract]   [Full Text] [Related]  

  • 70. The effect of aqueous humor ascorbate on ultraviolet-B-induced DNA damage in lens epithelium.
    Reddy VN; Giblin FJ; Lin LR; Chakrapani B
    Invest Ophthalmol Vis Sci; 1998 Feb; 39(2):344-50. PubMed ID: 9477992
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Denoral (F.F. 65) in child otorhinolaryngology (clinical experimentation)].
    Berger M; Quichaud
    Rev Laryngol Otol Rhinol (Bord); 1968; 89(1):131-4. PubMed ID: 5754673
    [No Abstract]   [Full Text] [Related]  

  • 72. [Consensus conference on the rationale for use of anti-inflammatory agents in otorhinolaryngology].
    Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):5-40. PubMed ID: 15462021
    [No Abstract]   [Full Text] [Related]  

  • 73. [The potentials for using paracetamol in otorhinolaryngology].
    Pal'chun VT; Kriukov AI; Uzdennikov AA; Ogorodnikov DS; Pakhomov IL
    Vestn Otorinolaringol; 1994; (5-6):43-6. PubMed ID: 7856020
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Clinical study of a vegetable proteolytic (extranase) in otorhinolaryngology].
    Plisnier H; Verougstraete
    Rev Laryngol Otol Rhinol (Bord); 1968; 89(1):127-31. PubMed ID: 5743802
    [No Abstract]   [Full Text] [Related]  

  • 75. [Value of a new preparation for local use in aerosol form, Collu-Hextril. Apropos of 50 routine cases in otorhinolaryngology].
    Lacher
    Rev Laryngol Otol Rhinol (Bord); 1970; 91(1):142-4. PubMed ID: 5439213
    [No Abstract]   [Full Text] [Related]  

  • 76. [Experience in histaglobin-drug therapy of various otorhinolaryngologic diseases].
    Gol'dshteĭn MA
    Zh Ushn Nos Gorl Bolezn; 1972; 32(1):91-3. PubMed ID: 4111804
    [No Abstract]   [Full Text] [Related]  

  • 77. [Our experience with cytostatics in O.R.L].
    Rossi Vargas J
    An Otorrinolaringol Ibero Am; 1974; 1(1):151-60. PubMed ID: 4470683
    [No Abstract]   [Full Text] [Related]  

  • 78. Vitamin C: the dangers of calcium and safety of sodium ascorbate.
    Kalokerinos A; Dettman I; Dettman G
    Australas Nurses J; 1981 Mar; 10(3):22. PubMed ID: 6910420
    [No Abstract]   [Full Text] [Related]  

  • 79. [Mucitux in the treatment of acute inflammatory states in otorhinolaryngology. Apropos of 60 cases].
    Haguenauer JP; Vautel JM
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1981 Dec; 30(10):677-80. PubMed ID: 6459415
    [No Abstract]   [Full Text] [Related]  

  • 80. Orthomolecular oncology: a mechanistic view of intravenous ascorbate's chemotherapeutic activity.
    González MJ; Miranda-Massari JR; Mora EM; Jiménez IZ; Matos MI; Riordan HD; Casciari JJ; Riordan NH; Rodríguez M; Guzmán A
    P R Health Sci J; 2002 Mar; 21(1):39-41. PubMed ID: 12013679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.